China
Novo Nordisk to expand Beijing R&D centre
September 25, 2012Research and Development, Sales and Marketing Beijing, China, Novo Nordisk, R&D
Novo Nordisk is investing $100 million into enlarging its R&D facilities in Beijing into a state-of-the-art centre. Located in the …
China sees fresh wave of drug price cuts
September 21, 2012Manufacturing and Production, Sales and Marketing China, Lunt, NDRC, ageing
China has unveiled yet another round of price cuts to prescription medicines. The price cuts cover more than 200 formulations …
Pfizer and Hisun sign China generics deal
September 13, 2012Manufacturing and Production, Sales and Marketing China, Pfizer, branded generics, emerging markets, generics
Pfizer has unveiled a new joint venture with with China’s Zhejiang Hisun Pharmaceuticals. It is one of the first joint …
MedImmune signs China deal
September 11, 2012Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, China, MedImmune, WuXi, emerging markets, rheumatoid arthritis
MedImmune has sealed a joint venture with Shanghai-based WuXi AppTec to develop a novel biologic for autoimmune and inflammatory diseases …
China sets February 2013 deadline for excipient regulations
August 14, 2012Manufacturing and Production China, IPEC, SFDA, Taylor
China has moved swiftly ahead with new regulations governing quality rules for pharmaceutical excipients, including new requirements for pharma firms …
WuXi continues strong growth
August 14, 2012Manufacturing and Production China, WuXi
Chinese contract research firm Wuxi saw its revenue grow strongly in the second quarter, with its laboratory services playing a …
Huge increase in emerging market spending to lift pharma
July 16, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, IMS, emerging markets, pharmerging
The global pharmaceutical market is set to return to stronger growth of 5-7% by 2016, according to a new forecast. …
R&D, East & West: Lilly invests in its global research network
July 10, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia, China, R&D, diabetes, lilly
Eli Lilly officially opened its new research facilities at its R&D base in Erl Wood in Surrey in April. The …
China sets out quality rules for pharma excipients
July 3, 2012Manufacturing and Production China, GMP, IPEC, manufacturing
China’s State Food & Drug Administration has published a draft regulation laying out a number of new measures for boosting …
BMS invests $15 million in Asian diabetes programme
June 11, 2012Sales and Marketing Asia, BMS, China, India, Onglyza, diabetes
Bristol-Myers Squibb has invested $15 million into its ‘Together on Diabetes’ campaign in India and China. Together on Diabetes is …
China bans medicines formulated in toxic capsules
April 17, 2012Manufacturing and Production China, SFDA, impurities, manufacturing
China’s State Food and Drug Administration (SFDA) has banned the sale of 13 medicines thought to be manufactured using contaminated …
Innovating in China’s pharma market
April 12, 2012Research and Development AstraZeneca, China, R&D, Steve Yang, emerging markets
The challenges that China and the wider Asia region face in healthcare represent big opportunities for multinational pharma companies. Cases of …
Novasep expands in China, raises €40m for investments
April 3, 2012Manufacturing and Production China, Novasep, Shanghai, manufacturing
French processing equipment supplier Novasep has opened a new facility in China to meet what it says is increasing demand …
Asymchem plans additional investment in Dunhua facility
February 21, 2012Manufacturing and Production Asymchem, China, Dunhua, manufacturing
China’s Asymchem Laboratories says it plans to invest another $12 million in its recently-opened manufacturing facility in Dunhua, Jilin province, …
Pfizer closes in on $545m China generics deal
February 20, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, Hisun, Pfizer, Zhejiang, generics
Pfizer has moved a step closer to a deal with Shanghai-based Zhejiang Hisun Pharmaceutical to develop generic drugs in China. …
